...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
Reply New Message
Back To Forum List View
Icon president Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
6
BearDownAZ
May 10, 2022 12:08PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
4
Toinv
May 12, 2022 01:13PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
4
jbuffett62
May 13, 2022 09:54PM
Icon president Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
6
RVXoldtimer
May 14, 2022 01:15PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
6
narmac
May 17, 2022 08:06AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
2
KOO-KOO2
May 17, 2022 11:21AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
4
Toinv
May 18, 2022 10:38AM

Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial

posted on Jun 23, 2022 05:34AM
Log in to use the IP Check tool [?]

"The number of participants in a clinical study. The "estimated" enrollment is the target number of participants that the researchers need for the study."

 

Koo

1 Recommendations
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
4
Toinv
Jun 23, 2022 10:59AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
tada
Jun 28, 2022 07:42PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply